ProfileGDS4718 / 204257_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 72% 77% 73% 67% 78% 77% 72% 67% 69% 70% 76% 78% 79% 71% 72% 71% 74% 74% 80% 75% 72% 68% 70% 73% 74% 66% 72% 67% 71% 71% 76% 70% 64% 77% 78% 69% 72% 73% 76% 70% 75% 78% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.8087369
GSM549102patient 115, normal, homogenized [OPG study]6.9674372
GSM549104patient 119, normal, homogenized [OPG study]7.5773677
GSM549108patient 138, normal, homogenized [OPG study]7.0527673
GSM549119patient 077, normal, homogenized [OPG study]6.5985867
GSM549133patient 032, cancer, homogenized [OPG study]7.7194878
GSM549139patient 042, cancer, homogenized [OPG study]7.5463777
GSM549099patient 107, normal, homogenized [OPG study]6.9763872
GSM549109patient 139, normal, homogenized [OPG study]6.6132667
GSM549110patient 046, normal, homogenized [OPG study]6.7745369
GSM549114patient 063, normal, homogenized [OPG study]6.8481570
GSM549122patient 082, normal, homogenized [OPG study]7.4542876
GSM549134patient 033, cancer, homogenized [OPG study]7.6332878
GSM549136patient 036, cancer, homogenized [OPG study]7.8759679
GSM549140patient 044, cancer, homogenized [OPG study]6.9737771
GSM549111patient 047, normal, homogenized [OPG study]7.1174772
GSM549113patient 057, normal, homogenized [OPG study]6.9680271
GSM549132patient 031, cancer, homogenized [OPG study]7.2423474
GSM549137patient 038, cancer, homogenized [OPG study]7.2504574
GSM549142patient 047, cancer, homogenized [OPG study]7.5919280
GSM549100patient 110, normal, homogenized [OPG study]7.2869475
GSM549107patient 135, normal, homogenized [OPG study]7.0494572
GSM549115patient 068, normal, homogenized [OPG study]6.7362768
GSM549116patient 072, normal, homogenized [OPG study]6.9024870
GSM549120patient 078, normal, homogenized [OPG study]7.1092273
GSM549131patient 030, cancer, homogenized [OPG study]7.2988874
GSM549118patient 074, normal, homogenized [OPG study]6.5985666
GSM549129patient 027, cancer, homogenized [OPG study]7.1512272
GSM549123patient 088, normal, homogenized [OPG study]6.6687167
GSM549124patient 006, cancer, homogenized [OPG study]6.8862471
GSM549126patient 015, cancer, homogenized [OPG study]6.9168471
GSM549128patient 025, cancer, homogenized [OPG study]7.5172276
GSM549103patient 117, normal, homogenized [OPG study]6.8023870
GSM549117patient 073, normal, homogenized [OPG study]6.3401264
GSM549138patient 041, cancer, homogenized [OPG study]7.6052877
GSM549141patient 045, cancer, homogenized [OPG study]7.7585978
GSM549130patient 028, cancer, homogenized [OPG study]6.8074869
GSM549101patient 111, normal, homogenized [OPG study]7.0587272
GSM549105patient 128, normal, homogenized [OPG study]7.1249173
GSM549106patient 134, normal, homogenized [OPG study]7.5279976
GSM549112patient 048, normal, homogenized [OPG study]6.83170
GSM549125patient 011, cancer, homogenized [OPG study]7.2971675
GSM549127patient 024, cancer, homogenized [OPG study]7.7295578
GSM549135patient 035, cancer, homogenized [OPG study]7.5129176